Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mengyin Zhang"'
Autor:
Yanzhen Zhang, Huaigang Chen, Lang Hong, Hong Wang, Bin Li, Mengyin Zhang, Jiamei Li, Liu Yang, Fan Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Atherosclerotic heart disease (AHD) is a major cause of morbidity and mortality worldwide. Lowering low-density lipoprotein cholesterol (LDL-C) levels is a key strategy to prevent and treat AHD. Inclisiran is a novel siRNA drug that targets proprotei
Externí odkaz:
https://doaj.org/article/2ed9a00219ad4f05a7669eaa5eccf39c
Publikováno v:
Water, Vol 15, Iss 24, p 4227 (2023)
With environmental degradation and water scarcity becoming increasingly serious, it is urgent to carry out effective management of water resources. The key task of water environment monitoring is to conduct statistics and analysis of changes in water
Externí odkaz:
https://doaj.org/article/ca4011d7185a472090fca47d87766133
Autor:
Yun LIU, Mengyin ZHANG
Publikováno v:
Shiyou shiyan dizhi, Vol 43, Iss 1, Pp 128-135 (2021)
The lithology of shale reservoirs is complex and the types of storage porosity are diverse. The existing gas-bearing property evaluation system by petrophysical logging is not perfect. In order to deepen the understanding of the gas-bearing capacity
Externí odkaz:
https://doaj.org/article/0ad6d14e910a48679fac3eceeff9f320
Autor:
Zhaoming Lu, Xiaojing Shi, Fanghua Gong, Shenglei Li, Yang Wang, Yandan Ren, Mengyin Zhang, Bin Yu, Yan Li, Wen Zhao, Jianying Zhang, Guiqin Hou
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 6, Pp 1004-1019 (2020)
Dysregulation of mTORC1/mTORC2 pathway is observed in many cancers and mTORC1 inhibitors have been used clinically in many tumor types; however, the mechanism of mTORC2 in tumorigenesis is still obscure. Here, we mainly explored the potential role of
Externí odkaz:
https://doaj.org/article/8f6b8f1c07e542c1b6fac991eebadb85
Autor:
Vincent Libis, Niv Antonovsky, Mengyin Zhang, Zhuo Shang, Daniel Montiel, Jeffrey Maniko, Melinda A. Ternei, Paula Y. Calle, Christophe Lemetre, Jeremy G. Owen, Sean F. Brady
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-9 (2019)
Soil microorganisms are a rich source of bioactive molecules. Here, the authors present a targeted sequencing workflow that reconstructs the clustered organization of biosynthetic domains in metagenomic libraries from amplicon data, thus guiding the
Externí odkaz:
https://doaj.org/article/2be2b1b1e1544062afa735e20fcd1c7b
Autor:
Yingpu Yu, William M. Schneider, Maximilian A. Kass, Eleftherios Michailidis, Ashley Acevedo, Ana L. Pamplona Mosimann, Juliano Bordignon, Alexander Koenig, Christine M. Livingston, Hardeep van Gijzel, Yi Ni, Pradeep M. Ambrose, Catherine A. Freije, Mengyin Zhang, Chenhui Zou, Mohammad Kabbani, Corrine Quirk, Cyprien Jahan, Xianfang Wu, Stephan Urban, Shihyun You, Amir Shlomai, Ype P. de Jong, Charles M. Rice
Publikováno v:
Science Advances. 9
Hepatitis B virus (HBV) chronically infects an estimated 300 million people, and standard treatments are rarely curative. Infection increases the risk of liver cirrhosis and hepatocellular carcinoma, and consequently, nearly 1 million people die each
Autor:
Niv Antonovsky, Sean F. Brady, Mengyin Zhang, Zhuo Shang, Jeremy G. Owen, Paula Y. Calle, Jeffrey Maniko, Vincent Libis, Melinda A. Ternei, Daniel Montiel, Christophe Lemetre
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-9 (2019)
Nature Communications
Nature Communications
Sequencing of DNA extracted from environmental samples can provide key insights into the biosynthetic potential of uncultured bacteria. However, the high complexity of soil metagenomes, which can contain thousands of bacterial species per gram of soi
Autor:
Shenglei Li, Yandan Ren, Fanghua Gong, Mengyin Zhang, Wen Zhao, Xiao-Jing Shi, Guiqin Hou, Zhaoming Lu, Yang Wang, Bin Yu, Jianying Zhang, Yan Li
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 10, Iss 6, Pp 1004-1019 (2020)
Acta Pharmaceutica Sinica B, Vol 10, Iss 6, Pp 1004-1019 (2020)
Dysregulation of mTORC1/mTORC2 pathway is observed in many cancers and mTORC1 inhibitors have been used clinically in many tumor types; however, the mechanism of mTORC2 in tumorigenesis is still obscure. Here, we mainly explored the potential role of